ARUP Newsroom

Attendees will have the unique opportunity to tour ARUP Laboratories during the 2026 AMLI Annual Meeting.

ARUP Laboratories observed Cyclospora positivity rates increase from very low levels to unprecedented levels within a short period of time, highlighting the importance of providing clinicians and laboratorians with timely disease surveillance data, said Ben Bradley, MD, PhD, ARUP head of clinical operations for Infectious Disease.

ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry characterizes small neoplastic populations with greater sensitivity than conventional flow cytometry while requiring less specimen volume.

Visit ARUP at booth #4453 to learn more about what’s happening at the forefront of laboratory medicine, speak with our experts, and test your skills at parasite and blood cell identification.

Cyclospora are notoriously difficult to detect by traditional microscopy methods. ARUP offers robust, artificial intelligence (AI)-enhanced testing that can help providers diagnose cyclosporiasis and respond to current outbreaks.